|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 269, Issue 1 E33-E42, Copyright © 1995 by American Physiological Society
ARTICLES |
J. Fan, D. Char, A. J. Kolasa, W. Pan, S. R. Maitra, C. S. Patlak, Z. Spolarics, M. C. Gelato and C. H. Lang
Department of Surgery, State University of New York at Stony Brook 11794, USA.
Lipopolysaccharide (LPS) produces a rapid and sustained reduction in the circulating concentration of insulin-like growth factor I (IGF-I), which may be responsible, in part, for the alterations in protein metabolism observed in these animals. The purpose of the present study was to determine whether this drop was due to a decreased hepatic production of IGF-I and/or an increased clearance of the peptide from the blood. Four hours after intravenous injection of LPS the plasma IGF-I concentration was decreased 50%. IGF-I release by in situ perfused livers from control rats was constant throughout the 60-min perfusion period and averaged 111 +/- 3 ng/min. In contrast, hepatic IGF-I output was decreased 46% by in vivo LPS. In contrast, livers from LPS-injected rats released more IGF binding proteins-1, -2 and -4 than did control livers. Hepatic cell isolation indicated that LPS decreased the IGF-I content in Kupffer and parenchymal cells, but not endothelial cells, by approximately 45%. Pharmacokinetic analysis of blood 125I-IGF-I decay curves indicated that the half-life for whole body clearance of 125I-IGF-I from the circulation was not altered by LPS. However, LPS increased 125I-IGF-I uptake by spleen, liver, lung, and kidney while decreasing uptake by the pancreas and gastrointestinal tract. These results indicate that the LPS-induced decrease in blood IGF-I concentration is primarily due to a reduction in hepatic production, not a change in whole body peptide clearance, and that a decreased production by both parenchymal and Kupffer cells contributes to this alteration.
This article has been cited by other articles:
![]() |
C. H. Lang, R. A. Frost, E. Svanberg, and T. C. Vary IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E916 - E926. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-E. Kong, S. M. Firth, R. C. Baxter, and P. J. D. Delhanty Regulation of the acid-labile subunit in sustained endotoxemia Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E692 - E701. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Greenhalgh and D. J. Hilton Negative regulation of cytokine signaling J. Leukoc. Biol., September 1, 2001; 70(3): 348 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, R. A. Frost, L. S. Jefferson, S. R. Kimball, and T. C. Vary Endotoxin-induced decrease in muscle protein synthesis is associated with changes in eIF2B, eIF4E, and IGF-I Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1133 - E1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. R. Boisclair, J. Wang, J. Shi, K. R. Hurst, and G. T. Ooi Role of the Suppressor of Cytokine Signaling-3 in Mediating the Inhibitory Effects of Interleukin-1beta on the Growth Hormone-dependent Transcription of the Acid-labile Subunit Gene in Liver Cells J. Biol. Chem., February 11, 2000; 275(6): 3841 - 3847. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Kohli, M. C. Bhaskaran, T. Muthukumar, K. Thennarasu, K. Sud, V. Jha, K. L. Gupta, and V. Sakhuja Treatment-related acute renal failure in the elderly: a hospital-based prospective study Nephrol. Dial. Transplant., February 1, 2000; 15(2): 212 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Farrell, M. J. Fedele, T. C. Vary, S. R. Kimball, C. H. Lang, and L. S. Jefferson Regulation of protein synthesis after acute resistance exercise in diabetic rats Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E721 - E727. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, G. J. Nystrom, and R. A. Frost Regulation of IGF binding protein-1 in Hep G2 cells by cytokines and reactive oxygen species Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G719 - G727. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Wojnar, J. Fan, Y. H. Li, and C. H. Lang Endotoxin-induced changes in IGF-I differ in rats provided enteral vs. parenteral nutrition Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E455 - E464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, R. A. Frost, J. Ejiofor, D. B. Lacy, and O. P. McGuinness Hepatic production and intestinal uptake of IGF-I: response to infection Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1291 - G1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, J. Fan, M. M. Wojnar, T. C. Vary, and R. Cooney Role of central IL-1 in regulating peripheral IGF-I during endotoxemia and sepsis Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R956 - R962. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |